Commercializing discontinuous innovations

Rapid changes in technology, and the incompatibility, between the culture o f an established corporation and a startup company, make it difficult for m any, large corporations to maintain their technological edge, even with the ir access to more resources and widespread distribution systems. However, t he capital markets enable an approach to commercializing discontinuous inno vations in a time of creative destruction based on leveraging the "patient money," aspect of venture capital. Such an approach may, well shape the 21s t century information technology corporation and its central R&D laboratory .